Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Similar documents
Medicines recommended to prevent and manage the priority diseases at the community and health facility level

Sources and Prices of Medicines for Children.

A Call to Action Children The missing face of AIDS

Rationalization of the Pediatric Antiretroviral Formulary to Optimize Pediatric Antiretroviral Treatment in Malawi

IATT Optimal List of Paediatric ARV Formulations: Background and Update

Update on the IATT Paediatric Formulary. WHO/UNAIDS Consultation with manufacturers March 2015, Geneva, Switzerland

The International Pharmacopoeia - Overview

Il programma dei farmaci essenziali dell OMS, la nuova lista marzo Suzanne Hill Department of Medicines Policy and Standards WHO

List of Optimal Paediatric Formulations. Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013

Application for Inclusion of Lopinavir /Ritonavir Oral Granules (LPV/r) Formulation on WHO Model List of Essential Medicines for Children

Strategies to Control Pneumonia and Diarrhoea: Tackling the deadliest diseases for the world s poorest children

Invitation to Manufacturers 16 August 2017

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

Paediatric ART Working Group. guideline review meetings

The pathway to better medicines for children

Existing and most needed paediatric ARV formulations

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN

Guidelines for management of suspected sepsis in young infants where referral is not possible

CHILDREN S MEDICINES IN UGANDA

The Global Accelerator for Paediatric Formulations (GAP-f) Ensuring children have accelerated access to optimal drug formulations

Management of Multidrug- Resistant TB in Children. Jennifer Furin, MD., PhD. Sentinel Project, Director of Capacity Building

What essential medicines for children are on the shelf?

Clinton Foundation HIV/AIDS Initiative ARV Procurement Forecast Tool Version 1.4 March, User s Manual

Integrated Community Case Management (iccm) and the role of pneumonia diagnostic tools

Frequently Asked Questions on Zinc and Suggested Responses

Fixed Dose Combination a Simplified Approach to Pediatric Antiretroviral Treatment

Dr. Rai Muhammad Asghar Associate Professor of Pediatrics Benazir Bhutto Hospital Rawalpindi

Pediatric ARV Working Group Dosing Recommendations

Department of Pediatrics RGH Rawalpindi Medical College

Adherence to case management guidelines of IMCI by health care workers in Tshwane

Child Health Services Tanzania Service Provision Assessment (TSPA)

MMV s Access & Product Management Strategy

INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS FOR HIGH HIV SETTINGS

Babies 1500g. Caffeine citrate. Sodium Acid Phosphate (1mmol/ml) Ferrous Fumarate (Galfer 140mg/5ml) Infloran. Abidec BMF

Nutrition Procurement Overview

NEW PNEUMONIA CASE MANAGEMENT GUIDELINES. By Andolo Miheso,Christine Wambugu, Sophie Ngugi, Warfa Osman (NCAHU MOH) & Ambrose Agweyu (KWT)

Challenges along the paediatric ARV pipeline Summary: IAS-ILF Industry Roundtable on Paediatric ARVs. Presented by Shaffiq Essajee (CHAI, USA)

MATERNAL, NEWBORN, AND CHILD HEALTH

UNICEF/Malawi/2015/Schermbrucker. policy brief 2016 UPDATE

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines

CADO/PADO: Update on 2015 WHO Consolidated guidelines Towards Treat All in the context of SDGs

Overview of UNICEF engagement in health & supply. Supply Division, 27 September 2010

Have new initiatives to improve availability made a difference?

Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1

Toolkit on monitoring health systems strengthening MEDICAL PRODUCTS, VACCINES AND TECHNOLOGIES

INITIATING ART IN CHILDREN: Follow the six steps

ANTIRETROVIRAL (ART) DRUG INFORMATION FOR HEALTH CARE PROFESSIONAL

Essential Medicines: update on policies and standards

TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV

TB/HIV Monitoring & Advocacy Project Interview Tool

International initiatives on extemporaneous dispensing

1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017

Figure S1: Overview of PMTCT Options A and B. Prevention of Mother to Child HIV Transmission (PMTCT)

18 July 2009 The 1st International Workshop on HIV Pediatrics Cape Town, South Africa

The New National Guidelines. Feeding in the Context of HIV. Dr. Godfrey Esiru; National PMTCT Coordinator

Innovation, Access and Use Department of Essential Medicines and Health Products WHO

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

An innovative mechanism for scaling up access to medicines and diagnostics for HIV/AIDS, tuberculosis and malaria

Paediatric ART: eligibility criteria and first line regimens. (revised) Dave le Roux 13 August 2016

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016

Paediatric ARV Procurement Working Group Progress Review at 31 December 2015

UNITAID. AMDS Partners Meeting. UNITAID Strategy & 2013 Call for Letters of Intent. Brenda Waning. Page 1

Product Characteristics and Product Information Links between Quality and Clinical

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

New Directions on WHO ARV Guidelines 2018

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

Pneumococcal Vaccine Introductions Dr. Carsten Mantel WHO/FCH/IVB/EPI

Paediatric HIV Resistance. Mohern Archary Paediatric Infectious Diseases Unit King Edward VIII Hospital / University of KwaZulu Natal

UNICEF and the 2030 agenda for Sustainable Development; Focus on Health

Caring for sick children in the community: Experiences from Malawi. Humphreys Nsona IMCI Unit

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York

Antibiotic Protocols for Paediatrics Steve Biko Academic Hospital

Revised National Tuberculosis Control Programme

QUESTIONS AND ANSWERS

Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)

CCC ARV Dosing Recommendations for HIV-exposed infants Updated

Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children WHO Headquarters, Geneva, Switzerland

Care of the HIV-Exposed Infant

Management of Tuberculosis Training for Health Facility Staff. F: Manage Drugs and Supplies for TB. WORLD HEALTH ORGANIZATION Geneva

Industry Perspective on Formulation and Packaging Considerations

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT

Nutrition Update Severe acute malnutrition

INTRODUCTION. WHO/Christopher Black

Ministry of Health, Pharmacy Division STOCK STATUS REPORT AS AT NOVEMBER 1st 2013

UNICEF/WHO Technical Consultation: IMPROVING ACCESS TO APPROPRIATE PAEDIATRIC ARV FORMULATIONS. November 3-4, WHO Headquarters, Geneva, EB Room

Technical Guidance Note for Global Fund HIV Proposals. TREATMENT - Antiretroviral Treatment-infants, children and adults

Global initiatives and priority products for MNCH

Prequalification Programme Bioequivalence Assessment Update. Dr. John Gordon

APRIL Key Findings: Overall. Key Findings: Availability

Codeine and Paracetamol in Paediatric use, an Update 5 th October 2013

Category and Product-level Procurement and Delivery Planning Guide

A Layperson s Guide to Pediatric Formulation Development

Medication Calculations - part 1

Access to essential medicines 59

WHO/UNICEF JOINT STATEMENT

Review of recent changes in WHO and national paediatric care guidelines Dr. Chewe Luo UNICEF New York City, USA

Dorothy Mbori-Ngacha UNICEF

Outline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children?

WHO MODEL LIST OF ESSENTIAL MEDICINES APPLICATION

Transcription:

Priority essential medicines: identifying products Dr Suzanne Hill September 2010

The problem looks like this

Robertson, Forte, Trapsida & Hill. Bull WHO 2009

Robertson, Forte, Trapsida & Hill. Bull WHO 2009

Or this

WHO-UNICEF Plan, 2006 Work on a global project to make paediatric medicines a priority: Add missing essential formulations to the Model list in 2007; advise on doses Develop EML for children (2007-8) Update treatment guidelines (2007-9) Develop paediatric prescribing information a formulary Develop effective methods for provision of information at the point of care Collaborate with regulatory authorities to encourage appropriate drug development and approval processes in all regulatory authorities Develop quality standards for paediatric medicines Advocate for the development of paediatric medicines by the industry Develop a system for enhancing safety monitoring of medicines in children Provide guidance on procurement and supply of paediatric medicines

Essential medicines for children World Health Assembly Resolution 'Make Medicines Child Size' Normative work, research needs Medicines for specific conditions Specifications for dosage forms Improving use of medicines in children National implementation

Preliminary consultation September 6-7 Participants from academia, procurement, donors, industry, other stakeholders Review of possible priority essential medicines for children Identify existing products that can be used Identify what is mssing Next steps

principles To treat: burden of disease, based on current treatment guidelines Clinical approach Weight based dosing for preference Consideration of different prescribers Strategies to enhance adherence Simplified dosing regimens Technology feasible Consideration of regulatory issues

Background Main burden of disease in children Neonatal infections Diarrhoea Pneumonia Malaria HIV TB

Global Causes of Child Deaths Black et al. Lancet, 2010 WHO. The World Health Statistics 2010 Black et al. Lancet, 2008 35% of under five deaths are associated with undernutrition

Diarrhoea Medicine Form and strength Pack size Regimen ORS As specified (low osmolarity) 1 litre, 200 and 500 ml According to the dehydration status/guidelines Zinc Sulphate 10 or 20 mg FSOD 10 of either Once daily for 10 days NOTE : combination product would be appropriate

Pneumonia - Low HIV setting Category Medicine Form and strength Pack size Regimen Pneumonia (Fast breathing) Oral amoxicillin 250 or 500 mg FSOD 10 of either Twice daily, 5 days Severe pneumonia (Chest Indrawing) Oral amoxicillin 250 or 500 mg FSOD 10 of either Twice daily, 5 days Very severe pneumonia (danger signs) Oxygen, Ampicillin + gentamicin or ceftriaxone Cylinder/oxygen concentrators -500 mg or 1 G -20 mg or 40 mg/ml 500 mg or 1 G Variable Pack?? Single dose As needed Variable daily x 10 days 50-100 mg/day 5 days NOTE: cotrimoxazole may be an alternative for pneumonia/fast breathing

Pneumonia: High HIV setting Category Medicine Form and strength Pack size Regimen Pneumonia (Fast breathing) Oral amoxicillin 250 or 500 mg FSOD 10 of either Twice daily, 5 days Severe pneumonia (Chest Indrawing) Ampicillin + gentamicin or ceftriaxone -500 mg or 1 G -20 mg or 40 mg/ml 500 mg or 1 G Pack?? Single dose Variable daily x 10 days 50-100 mg/day 5 days Very severe pneumonia (danger signs) Oxygen, Ampicillin + gentamicin or ceftriaxone Cylinder/oxygen concentrators -500 mg or 1 G -20 mg or 40 mg/ml 500 mg or 1 G Variable Pack?? Single dose As needed Variable daily x 10 days 50-100 mg/day 5 days

Malaria Category Medicine Form and strength Pack size Regimen Malaria (uncomplicated) Artemeter +Lumefantrine (FDC) Artesunate + amodiaquine (FDC) Variable FSOD see treatment guideline For 3 day treatment 6x1 & 6x2 (30 blisters per box) 3 (25 blisters per box) Daily or twice daily x 3 days Malaria (severe or pre-referral) Artesunate Quinine hydrochloride 60 mg Injection 152 mg/ml injection?50/pack 100 ampoules/pack 2.4 mg/kg iv, 3 doses, then daily; 20mg infusion then 10mg/kg 8 hrly Artesunate rectal 50, 100, 200 mg Suppositories 6 per pack 10 mg/kg dose

HIV Category Medicine Form and strength Pack size Regimen HIV treatment AZT+3TC+NVP (< 3 years) AZT+3TC+EFV (>3 years) 60+ 30 mg+50 mg FDC tablet, scored the 2nd one not available 30 days Once or twice daily HIV - Prophylaxis Isoniazid Cotrimoxazole 100 mg TMP 80+SMX 400mg; TMP 20+SMX 100 mg 30 days 30 days 10 mg/kg 20-80 mg TMP /day age related doses

HIV ARV Prophylaxis Category Medicine Form and strength Pack size Regimen Breastfeeding population NVP 15mg once daily (10mg for low birth weight) Strength?? Form?? 30 days Variable according to weight and age Daily from birth until one week after all exposure to breastmilk Non breastfeeding population AZT or NVP 15mg twice daily or 15 mg once daily Strength?? Form?? 15 days? 45 days Variable according to weight and age For 4-6 weeks All exposed infants AZT or NVP 15mg twice daily or 15 mg once daily Strength?? Form?? 15 days? 45 days Variable according to weight and age For 4-6 weeks

Neonates Category Medicine Form and strength Pack size Regimen Neonatal sepsis Ampicillin + gentamicin or ceftriaxone Procaine penicillin? -500 mg or 1 G - 20 mg /ml 500 mg or 1 G?? Single dose Single dose -50 mg/kg x2 doses for 1 week and x3 doses for 2-4 wk - 4-5 mg/kg/day in 0-6 days and 5-6.5 mg/kg in 7-59 days x 1-50 -100 mg/kg /day -40,000-60,000 units/kg/day Neonatal care Chlorhexidine Vitamin K Caffeine citrate 4% solution 1 mg/1 ml, 10 mg/ml 20mg/ml injection or oral liquid?? 500 ml Variable Variable Topical application 0.5 1 mg x 1 at birth; 5mg/kg/day

Miscellaneous Category Medicine Form and strength Pack size Regimen Child survival Vitamin A 100,000 units capsule variable 100,000 units every 6 months Pain Paracetamol Variable FSOD 5-10 days supply 15 mg/kg 4-6 hours Morphine 10 mg oral dosage form 5 days Variable every 6 hours 10m/ml injection

TB Category Medicine Form and strength Pack size Regimen Treatment intensive phase, 2 months Isoniazid Rifampicin Pyrazinamide ethambutol 4 component FDC, flexible oral solid dosage form containing 150+250+400+250 30 days In this does, weight based dosing, once daily Or product with same ratio Treatment, continuation phase, 4 months Isoniazid Rifampicin Pyrazinamide 3 component FDC, flexible oral solid dosage form containing 150+250+400 Or 2 component FDC, flexible oral solid dosage form

FULL ASSET PROFILE: Amoxicillin Attribute Worst case BASE CASE Best case Comment Summary Profile Description Objective / Rationale Develop a dispersible amoxicillin product for pediatric patients in the developing world target age range? Dosing Regimen Twice daily Weight based dosing: 2-4kg 0.5 x 250mg tablet bd 5-9kg 1 x 250mg tablet bd 10-20kg 1 x 500mg tablet bd 21-30kg 2 x 500mg tablet bd Presentation (form and pack size) sachet? Taste-masked, dispersible tablet. Pack size 10 meltaway formulation flavor preferences? Can it be given in breast milk? Strength 250mg or 500 mg Both in packs of 10 Duration of Therapy Quality Standard Scoring 5 days SRA approval - WHO PQ, US FDA, or equivalent yes Packaging Blister packs? Any labeling requirements? Stability/shelf life Estimate Year of Launch Selling Price XX XXX XX Royalties 2 years minimum, zone 4 stability, store at or below X C 3 or more years no cold chain requirements *Prices taken from WHO/UNICEF Sources and prices of selected medicines for children 2010. Median price (USD) per dose, unless otherwise stated. XXX Current amoxicillin price*: 250 mg dispersible 0,022; 500 mg capsule 0,032; 250 mg capsule 0,018 will developing company get to charge "reasonable" or get other market advantage?

Weight based dosing Examples Antiretrovirals First line treatments for TB Amoxicillin

Amoxicillin/ cotrimoxazole weight (kg) amoxicillin bd (at least 50mg per day) cotrimoxazole bd (TMP at least 8mg/day) 250 total mg/kg per day 500 total mg/kg per day 100+20 (TMP) total mg/kg per day 400+80 (TMP) total per day tabs per dose tabs per dose tabs per dose tabs per dose 2 0.5 125.0 1 20.0 3 0.5 83.3 1 13.3 4 0.5 62.5 1 10.0 5 1 100.0 1 8.0 0.5 16.0 6 1 83.3 2 13.3 0.5 13.3 7 1 71.4 2 11.4 0.5 11.4 8 1 62.5 2 10.0 0.5 10.0 9 1 55.6 2 8.9 0.5 8.9 10 1 100.0 2 8.0 1 16.0 11 1 90.9 3 10.9 1 14.5 12 1 83.3 3 10.0 1 13.3 13 1 76.9 3 9.2 1 12.3 14 1 71.4 3 8.6 1 11.4 15 1 66.7 3 8.0 1 10.7 16 1 62.5 4 10.0 1 10.0 17 1 58.8 4 9.4 1 9.4 18 1 55.6 4 8.9 1 8.9 19 1 52.6 4 8.4 1 8.4 20 1 50.0 4 8.0 1 8.0

Strategies to enhance adherence Packaging and labelling Artemether-lumefantrine What pack size for long term treatments? TB, HIV What approach will work for community based administration of antibiotics?

Technology/dosage form Oral versus not Stable, long shelf life Avoiding liquids Flexible oral solid dosage form Simplified dosing schedules, weight based dosing

Regulatory questions - product Does a change of doing regimen need a change of label? Amoxicillin? What about pack size? 10 versus 21? What about different FDCs without an innovator? HIV, TB?

'Sure' ORS But with a smaller sachet and flavour, pack of 10 Zinc 20mg scored dispersible- with ORS ACT(s) Dispersible / FOSD dose optimised see WHO guidelines Artesunate Rectal, and injection (but better) HIV FDC (s) - see WHO guidelines Nevirapine, zidovudine Amoxicillin dispersible, scored 250 and 500, pack of 10 Oxygen TB FDCs next slide Analgesics paracetamol ( dispersible), morphine Vitamin A 100,000 IU

Work needed TB FDC correct component strength** Artesunate - injection and rectal 50-200mg dose range (10mg/kg) Caffeine citrate standard product, market readiness - 20mg/ml, liquid and injection Chlorhexidine solution, 4% regulatory pathway and patient pack Isoniazid / cotrimoxazole product strength not yet known for prophylaxis (HIV co pack?)

Problems -TB rifampicin: 15 mg/kg/d (10 to 20 mg/kg/day) isoniazid: 10 mg/kg/d (10 to 15 mg/kg/day) pyrazinamide: 35 mg/kg/d (30 to 40 mg/kg/day) ethambutol: 20 mg/kg/d (15 mg to 25 mg/kg/d) WANTED - Fixed Dose Combination (FDC) containing rifampicin 250 mg, isoniazid 150 mg, pyrazinamide 400 mg, and ethambutol 250 mg Dose: 0.5 to 2.0 'tablets' per day, 5-30 kg

Problems - TB

Solutions needed

Clinical evidence needed Optimised dosing regimens for Vitamin K? Gentamicin Ampicillin Procaine penicillin Ceftriaxone

Priority essential medicines for children Priority Essential Necessary

Priority essential medicines for children Necessary Essential Priority

Where is my essential medicine?